About the Company
Established in 2003, Biocompounds Pharmaceutical Inc. (BPI) is an innovative company in China, dedicating to the production of high-end generic drug with license permission and specializing in customized new drug research and development for domestic and foreign pharmaceutical companies. Our company has been honored as the High-tech Enterprise in Shanghai, the New Special Expertise Enterprise in Shanghai, and will continue to ...
Established in 2003, Biocompounds Pharmaceutical Inc. (BPI) is an innovative company in China, dedicating to the production of high-end generic drug with license permission and specializing in customized new drug research and development for domestic and foreign pharmaceutical companies. Our company has been honored as the High-tech Enterprise in Shanghai, the New Special Expertise Enterprise in Shanghai, and will continue to grow with the development of pharmaceutical industry.
Biocompounds derives from antitumor studying team of SIMM, Chinese Academy of Sciences, with professional and efficient R&D and technical support teams. BPI carry out innovative projects cooperation together with Fudan University, East China Normal University, Jiangsu University, and Shanghai University of Engineering Science. In more than 10 years, we regarded technical innovation as the forerunner and quality as the focus, and laid solid foundation for our industry. As a high-tech enterprise, we have totally applied 19 patents of invention, undertaken 6 provincial technical tasks, and was awarded the Second Prize of Songjiang District Scientific and Technology Progress. Meanwhile?BPI have obtained ISO9000 certification ,with ‘Quality Shapes Future’ as its tenet and set the quality principle as ‘Quality-Centric, Customer-Oriented, Innovation-Driven and Continuous Improvements’. We are the first supplier of many first-class domestic and foreign pharmaceutical enterprises and utilize many kinds of market strategies, for technical service, strategic cooperation, channel development, products management, and so on. We seek self-development by creating values for customers.
In recent years, Biocompounds strengthened talent reserves and team culture. Increased amount of outstanding members join us, including masters, doctor and post-doctor which made BPI be further on the way to specialization. Our R & D center, an 800 square meter building, was extended to two buildings. At the core of GMP, we set up a creative and innovative base. Meanwhile, we developed more cooperative production base to further expand our manufacturing capability. Besides cooperating with CGMP pharmaceutical factory, we merged one unique API production base in ANHUI province GMP and planned to build multiple product lines in order to lay a foundation for “BPI Made-in-China 2025”. Nowadays, Biocmpounds has already built a platform which integrates independent research and development, technical service and the production amplification. Not only can Biocompounds provide various kind of API and its advanced intermediates, but also can provide abundant technique and documents support. So we are confident to serve customers one-stop process development, quality research and industrialization solutions. In the unending changing online world, Biocompounds open it’s multimedia market, providing ‘BPI online service’. We extended our market from domestic market, including Jiangsu province, Henan province, Hubei province, Shandong province, Jiangxi province, Anhui province, Chongqing province, Zhejiang province, Guangdong province and shanghai province, to India, even to Europe.
Related Companies
Market Place
